Chiesi Farmaceutici S.p.A. is a global pharmaceutical company with a strong commitment to research, development, and commercialization of innovative therapeutic solutions. The company focuses on respiratory, neonatology, rare diseases, and special care therapeutic areas. With a presence in over 30 countries, Chiesi is dedicated to improving the quality of human life by acting responsibly towards the environment and society.

Chiesi Farmaceutici is recognized for its sustainability efforts and has been a certified B Corporation since 2019. This certification underscores the company's commitment to meeting high standards of social and environmental performance, accountability, and transparency. Chiesi aims to achieve carbon neutrality by 2035 and has implemented various initiatives to reduce its carbon footprint, including the use of renewable energy sources and sustainable packaging solutions.

The company publishes an annual Sustainability Report, which details its progress and goals in environmental, social, and governance (ESG) areas. Chiesi is also involved in numerous community and social projects, reflecting its dedication to creating a positive impact beyond its business operations. The company's efforts in sustainability are guided by the United Nations Sustainable Development Goals (SDGs), ensuring a comprehensive approach to global challenges.